Immune Biotech Private Limited
About Immune Biotech Private Limited
Data last updated:
Immune Biotech Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the diversified operations segment of the manufacturing sector. It was incorporated on 21 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U36999MH2019PTC333404. Its GSTIN is 27AAFCI4776D1ZG (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kareem Rahmtulla Kureshi and Raheem Rahmatulla Kureshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O. Mr. Akhtar Kureshi Plot No. 17 Prabhag No. 10 Wanadongri Hingna, Nagpur, Maharashtra, India – 441110.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.17 Cr, a growth of 88% compared to the previous year. For the same year it recorded a net profit of ₹6.3 Lakh (net margin 5.4%) and EBITDA of ₹9.05 Lakh (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 69% over three years.
Company details
Contact details
Immune Biotech Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressC/O. Mr. Akhtar Kureshi Plot No. 17 Prabhag No. 10 Wanadongri Hingna, Nagpur, Maharashtra, India – 441110
- IndustryManufacturing, Other, Manufacturing
To see the full contact details of Immune Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Immune Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Immune Biotech Private Limited, buy the company report.
Financials of Immune Biotech Private Limited
FY 2025 filings availableImmune Biotech Private Limited reported revenue of ₹1.17 Cr (up 88% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 69% over three years, including 88% growth in the latest year. EBITDA rose 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immune Biotech Private Limited, buy the company report.
Board of directors of Immune Biotech Private Limited
Immune Biotech has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kareem Rahmtulla Kureshi | Director | 21 Nov 2019 | 6 Years 11 Months | Current |
| Raheem Rahmatulla Kureshi | Director | 11 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Immune Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dexcor Specialities Private Limited | ₹1.18 Cr (FY 2020) | 63.0% | Vadodara, Gujarat, India | |||
| Xperia Healthcare Private Limited | ₹1.18 Cr (FY 2024) | -5.0% | Vasai, Maharashtra, India | |||
| Avillions Laboratories Private Limited | ₹1.18 Cr (FY 2022) | 180.0% | Roorkee, Uttarakhand, India | |||
| Cydia Health Care Private Limited | ₹1.18 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Maa Mangala Industries Private Limited | ₹1.18 Cr (FY 2024) | 23.0% | Barbil, Odisha, India | |||
| Immune Biotech Private Limitedthis company | ₹1.17 Cr (FY 2025) | ₹6.3 Lakh | 5.4% | 88.0% | Nagpur, Maharashtra, India | |
| Zywie Pharmaceuticals Private Limited | ₹1.17 Cr (FY 2019) | 552.0% | Hyderabad, Telangana, India | |||
| SJV Biotech Private Limited | ₹1.17 Cr (FY 2024) | 80.0% | New Delhi, Delhi, India | |||
| Hicon Dye Industries Private Limited | ₹1.17 Cr (FY 2024) | Wankaner, Gujarat, India | ||||
| Shrimali Organic Private Limited | ₹1.17 Cr (FY 2025) | 45.0% | Varanasi, Uttar Pradesh, India | |||
| Prismatic Assotech Private Limited | ₹1.17 Cr (FY 2025) | 9921.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Immune Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Immune Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immune Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Immune Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI4776D1ZG | Maharashtra | Active | 31 Dec 2019 |
To see the full GST registrations and return filing status of Immune Biotech Private Limited, buy the company report.
Recent activity
Immune Biotech Private Limited has 6 board changes on record since 2019: 3 appointments and 3 cessations. The latest: Raheem Rahmatulla Kureshi was appointed as Director on 11 Sep 2025.
Frequently asked questions
Immune Biotech is an active private limited company based in Nagpur, Maharashtra, India. The company works in other, within the manufacturing industry. It was incorporated on 21 November 2019 (7+ years old) and is registered under CIN U36999MH2019PTC333404.
Immune Biotech has 2 current directors:
- Kareem Rahmtulla Kureshi - Director
- Raheem Rahmatulla Kureshi - Director
The latest financial statements of Immune Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Immune Biotech is 27AAFCI4776D1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Immune Biotech is U36999MH2019PTC333404. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immune Biotech was incorporated on 21 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Immune Biotech by revenue are Dexcor Specialities Private Limited, Xperia Healthcare Private Limited, Avillions Laboratories Private Limited, Cydia Health Care Private Limited, Maa Mangala Industries Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Raheem Rahmatulla Kureshi was appointed as Director on 11 Sep 2025. Shaba Kausar Kareem Kureshi ceased to be Director on 11 Sep 2025. Shaba Kausar Kareem Kureshi was appointed as Director on 09 Jan 2020. Immune Biotech has 6 board changes on record in total.
The registered office of Immune Biotech is at CO. Mr. Akhtar Kureshi Plot No. 17 Prabhag No. 10 Wanadongri Hingna, Nagpur, Maharashtra, India – 441110.
Immune Biotech operates in the manufacturing industry, in the other segment.
Immune Biotech can be reached at its registered office: CO. Mr. Akhtar Kureshi Plot No. 17 Prabhag No. 10 Wanadongri Hingna, Nagpur, Maharashtra, India – 441110.